| Identification | Back Directory | [Name]
UK-101 | [CAS]
1000313-40-5 | [Synonyms]
UK-101
Heptanamide, N-[(1S)-2-[[(1S)-1-[[(2S)-2-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2-oxiranyl]carbonyl]-3-methylbutyl]amino]-1-methyl-2-oxoethyl]- | [Molecular Formula]
C25H48N2O5Si | [MDL Number]
MFCD34469255 | [MOL File]
1000313-40-5.mol | [Molecular Weight]
484.74 |
| Chemical Properties | Back Directory | [Boiling point ]
624.9±55.0 °C(Predicted) | [density ]
1.009±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
13.33±0.46(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Description]
UK-101 is a potent and selective immunoproteasome β1i (LMP2) inhibitor. UK-101 induces cell apoptosis and can be used for the study of prostate cancer. |
|
| Company Name: |
|
| Tel: |
|
| Website: |
www.sangon.com |
|